Temat: novel therapies - Katalog OPAC zbiorów

Skocz do pozycji: 1.

Tytuł:: Civilization diseases – therapeutic application of antisense strategy
Autorzy:: Bąkowska-Żywicka, Kamila
Tyczewska, Agata
Twardowski, Tomasz
Powiązania:: https://bibliotekanauki.pl/articles/703440.pdf
Data publikacji:: 2008
Wydawca:: Polska Akademia Nauk. Czytelnia Czasopism PAN
Tematy:: civilization diseases
antisense oligonucleotides
novel therapies
Opis:: Modulation and regulation of biosynthesis process by means of antisense oligonucleotides lay the foundation for new therapeutic strategies, among others against cancer, viral or angiogenesis diseases. The aim of this account is the presentation of molecular basis of antisense strategy and mechanism of action of antisense oligonucleotides. Furthermore we present the state of art in clinical studies of application of antisense oligonucleotides in some of civilization diseases.
Źródło:: Nauka; 2008, 1
1231-8515
Pojawia się w:: Nauka
Dostawca treści:: Biblioteka Nauki

Artykuł

Skocz do pozycji: 2.

Tytuł:: Multiple sclerosis – new therapeutic directions
Autorzy:: Łowiec, Paweł
Trzonkowski, Piotr
Chwojnicki, Kamil
Powiązania:: https://bibliotekanauki.pl/articles/895817.pdf
Data publikacji:: 2019-06-04
Wydawca:: Gdański Uniwersytet Medyczny
Tematy:: multiple sclerosis
neuroprotection
novel therapies
remyelination
gut microbiome
Opis:: Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease which affects the central nervous system. Currently, there are numerous disease-modifying therapies for this condition. Most of them address the inflammatory aspects of the disease and are most effective in the relapsing-remitting stages of multiple sclerosis. However, none of them can completely stop the progression of MS and they are usually associated with adverse effects. There is an ongoing search for novel approaches that involve different modes of action. Here, we discuss examples of new immunomodulating agents such as antigen-specific therapies, neuroprotectants, regenerative strategies and gut microbiota modification.
Źródło:: European Journal of Translational and Clinical Medicine; 2019, 2, 1; 7-22
2657-3148
2657-3156
Pojawia się w:: European Journal of Translational and Clinical Medicine
Dostawca treści:: Biblioteka Nauki

Artykuł

Informacja